Dexcom (DXCM)

Dexcom Stock Analysis & Ratings

DXCM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$67.11 - $659.45
Previous Close$78.46
Average Volume (3M)3.54M
Market CapN/A
Enterprise ValueN/A
P/E Ratio151.6
Next EarningsJul 28, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score9



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $67.11 and its highest was $659.45 in the past 12 months.
    What is Dexcom’s market cap?
    Currently, no data Available
    What is Dexcom’s price target?
    The average price target for Dexcom is $117.23. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $140.00 ,the lowest forecast is $87.00. The average price target represents 49.62% Increase from the current price of $78.35.
      What do analysts say about Dexcom?
      Dexcom’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
        When is Dexcom’s upcoming earnings report date?
        Dexcom’s upcoming earnings report date is Jul 28, 2022 which is in 21 days.
          How were Dexcom’s earnings last quarter?
          Dexcom released its earnings results on Apr 28, 2022. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.131 by -$0.051.
            Is Dexcom overvalued?
            According to Wall Street analysts Dexcom’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Dexcom pay dividends?
              Dexcom does not currently pay dividends.
              What is Dexcom’s EPS estimate?
              Dexcom’s EPS estimate is $0.19.
                How many shares outstanding does Dexcom have?
                Dexcom has 392,503,720 shares outstanding.
                  What happened to Dexcom’s price movement after its last earnings report?
                  Dexcom reported an EPS of $0.08 in its last earnings report, missing expectations of $0.131. Following the earnings report the stock price went down -1.133%.
                    Which hedge fund is a major shareholder of Dexcom?
                    Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.


                      Dexcom Stock Analysis

                      Smart Score
                      Price Target
                      ▲(49.62% Upside)
                      Strong Buy
                      The Dexcom stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description


                      California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.

                      Similar Stocks
                      Price & Change
                      Johnson & Johnson
                      Senseonics Holdings
                      Roche Holding
                      Tandem Diabetes Care

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis